DRUG

high-dose VPA

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for high-dose VPA

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
STAT3 prurigo nodularis 0.208 Mid novel signal none

Clinical trials

17 registered trials for high-dose VPA

Source: ClinicalTrials.gov

← All drugs